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Reply to the Editor: 
My colleagues and I thank Masaoka and his associates for 
their letter and discussion. The authors point out one of the 
problems in dealing with tumors of the thymus: a variety of 
pathologic classifications have been devised, and the recent 
introduction of new classifications has caused a significant 
amount of confusion. A single classification of thymic tumors 
is greatly needed. 
We agree that well-differentiated thymic carcinoma is dif-
ferent from type II malignant thymoma. The point of our arti-
cle was that both of these malignant diseases can be aggres-
sive. We found that the tumors with the worst prognosis were 
those invading the innominate vein. Regardless of the patho-
logic diagnosis, fewer than 50% of patients treated for such 
tumors with complete resections will be disease-free at 5 
years, despite surviving. As Fig 1 in our original article 
demonstrates, even stage I and II thymic carcinoma will have 
a propensity to recur. In 10 years, 90% of thymic carcinomas 
of either type will recur, despite complete resection. 
We therefore concluded that either of these entities requires 
a much more aggressive management and might benefit from 
multimodality therapy. 
Robert J. Ginsberg, MD 
Department of Thoracic Surgery 
Memorial Sloan Kettering Cancer Center 
1275 York Ave 
New York City, NY 10021 
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Controlled cardiac reoxygenation in adults with 
ischemic heart disease 
To the Editor: 
We read with fascination the report by Kai Ihnken and 
associates I printed in the August 1998 issue of the Journal, in 
which standard, hyperoxic arterial POzs were compared with 
"normoxic" POzs during cardiopulmonary bypass (CPB) and 
found to cause measurable biochemical evidence of injury at 
the cellular level. We would like to ask several questions and 
to comment. Our questions relate to the initiation of anesthe-
sia in the patients who were subjected to normoxic CPB. The 
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common practice is for anesthesiologists to intubate and 
hyperoxygenate every patient, both during and after induc-
tion. Is this the way the patients in this group were handled? 
If so, could they not also have had an initial "reoxygenation" 
injury occurring at the time of anesthesia induction, if the POl 
of arterial blood was allowed to rise to extremely high levels 
before the initiation of CPB? Might the biochemical evidence 
of injury in the group subjected to hyperoxic bypass have 
been even more pronounced, by comparison, had prebypass 
POzs been controlled to physiologic levels upon intubation 
and induction of anesthesia in the other group of patients? 
Furthermore, might all of us be unintentionally contributing 
to injury of the heart in other clinical situations as well? 
We are in full agreement that the way in which oxygen is 
administered to adult patients with ischemic heart disease 
needs to be rethought. From our reading, it appears that this 
work represents a prolog to the introduction of "controlled 
cardiac reoxygenation," a concept borrowed from congenital 
heart surgery and used successfully in cyanotic children,z,3 
into another clinical area in which it may be applicable. This 
study suggests that, even in the adult patient with coronary 
heart disease and a "normoxic heart," considerable and cer-
tainly measurable cellular injury is occurring because of 
some of the known, toxic effects of high levels of molecular 
oxygen introduced abruptly into the coronary circulation. 
We would like to share our experience with the use of a 
strategy of controlled cardiac reoxygenation with 6 consecu-
tive patients taken to the operating room in the setting of 
advanced, evolving myocardial infarction. All were referred 
for emergency revascularization because catheter-based ther-
apies either were judged to be not feasible by the cardiologist 
or had failed to successfully interrupt the unstable syndrome. 
Half were in cardiogenic shock (pulmonary capillary wedge 
pressure> 18 mm Hg, cardiac index < 2.0 Llmin per square 
meter) at the time of entry to the operating room. All had 
multivessel coronary disease, profound diffuse myocardial 
contractile dysfunction (mean preoperative left ventricular 
ejection fraction was 28%), and had been having active 
symptoms for greater than 6 hours. Coexistent medical con-
ditions were what would be expected for such a patient pop-
ulation with a mean age of nearly 68 years. An average of 4 
bypass grafts was accomplished. In all 6 patients, deoxy-
genated blood cardioplegic solution was administered for ini-
tial warm induction and the POz of the reperfusate (initially 
35-45 mm Hg) was gradually raised over 20 minutes by alter-
ing the FIOZ of the membrane oxygenator and by changing the 
admixture of venous and arterial blood in the cardioplegia 
circuit. The pH of the initial cardioplegic solution, although 
from the venous side of the bypass circuit, was controlled in 
the normal range by adding bicarbonate or tromethamine as 
needed. The operations were completed with the use of inter-
mittent doses of cold (4°C) hyperoxygenated blood cardio-
plegic solution and a "hot shot" at the end of the crossclamp 
interval. In this group of patients, whom we expected to do 
relatively poorly on the basis of previous experience, we have 
had no deaths and the mean time to discharge from the hos-
pital was 8 days. The mean time to extubation for the group 
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has been 30 hours, and the mean predischarge left ventricular 
ejection fraction was 46%, representing a marked improve-
ment from the global depression seen at initial presentation 
(N. J. Thomas, MD, unpublished data). 
We believe our clinical observations have demonstrated the 
safety and feasibility of the technique described and fit with 
what Ihnken and associates seem to be saying. That is, 
extremely high levels of oxygen can injure the heart (in a Po2-
dependent fashion4) in even the best of elective circumstances, 
when the heart is normoxic. Furthermore, we believe that suf-
ficient laboratory data exist to support the concept that cellu-
lar injury, after abrupt reoxygenation of previously hypoxic 
myocardial and endothelial cells, certainly must be occurring 
during emergency reperfusion when the heart has been 
starved for oxygen for hours and hours in the working state. 
Our work grew out of the realization and frustration that 
surgical results in this type of patient had been poor previ-
ously, both historically and in our hands. Similarly, the pio-
neering work of the group at the University of California at 
Los Angeles,5 regarding the controlled reintroduction of mol-
ecular oxygen, examined specifically the cause for morbidity 
related to myocardial dysfunction in some infants and chil-
dren with cyanotic heart disease after corrective surgery. This 
led us to wonder whether advanced myocardial infarction 
might be another clinical scenario, albeit different, where this 
concept has applicability. Our surprising clinical results with 
the first 2 patients caused us to add to our strategy a reduction 
of initial FIo2 levels, such that arterial P02 remained physio-
logic (100-120 mm Hg), immediately on induction of anes-
thesia and intubation in such patients. This strategy was 
maintained and included initiation of CPB levels at normox-
ia, until gradual reoxygenation of the struggling heart could 
be accomplished. 
We endorse the further investigation of this paradigm shift 
and we are actively involved in our laboratory in doing so. We 
believe a safer way to reintroduce molecular oxygen in this 
setting now exists. Ihnken and associates have provided 
invaluable biochemical proof that we have probably been cor-
rect since we started "hypoxemic reperfusion" in April of 
1997 at Loyola University. We believe, further, on the basis of 
this article and other data,6,7 that the concept will be especial-
ly relevant when, at the cellular and molecular levels, the heart 
is poised to be overwhelmed by the influx of molecular oxy-
gen substrate, shown to be injurious in precisely that setting. 
We congratulate Ihnken and his associates on another fine 
article. This is a concept we believe has tremendous merit and 
may have applicability in several clinical settings. 
Neil J. Thomas, MD 
Eric Grassman, MD 
Michael Walloch, CCP 
Nicholas King, CCP 
Cardiovascular Research Foundation 
Phoenix, AZ 85006 
Division of Cardiology and Department of Thoracic and 
Cardiovascular Surgery 
Loyola University Medical Center 
Maywood, IL 60153 
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Reply to the Editor: 
I would like to thank Thomas and his colleagues for their 
interest in our recent article! and I appreciate their kind 
remarks. 
They are to be congratulated for their excellent clinical 
results in a subgroup of high-risk patients. Their findings are 
similar to our results in 37 patients with acute coronary 
occlusion treated with blood cardioplegic controlled coronary 
reperfusion.2 This concept of controlling the circumstances 
of initial reperfusion after ischemia was originally developed 
by Buckberg,3 long before we established controlled reoxy-
genation after hypoxemia.4 
It is important to distinguish between ischemia-reperfusion 
and hypoxia-reoxygenation injury, and not to interchange the 
two terms for different settings.5 Whereas there is normal or 
increased blood flow with nutritious blood during hypoxia, 
there is no blood supply to a completely ischemic area, which 
will become secondarily hypoxemic and acidotic. 
Reperfusion injury has a multifactorial cause, in which 
restoration of blood flow with normal blood at systemic pres-
sure (uncontrolled reperfusion) will cause lipid peroxidation, 
membrane damage, cell swelling, calcium overload, mito-
chondrial disruption, and myocardial necrosis.3 Controlled 
reperfusion incorporates mechanisms to control the composi-
tion of the reperfusate (calcium, substrates, osmolarity, pH, 
oxygen-derived free radical scavengers) and the circum-
stances of the initial reperfusion period (time, temperature, 
and pressure). Reduced oxygen content in the reperfusate is 
only one aspect, but all determinants have to be addressed to 
obtain the full beneficial effect. 3 
Reoxygenation injury after hypoxemia, in contrast, is main-
ly caused by oxygen-derived free radical production and can 
